XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 13,000 $ 8,525
Accounts receivable, net 5,453 5,087
Inventory, net 4,162 4,048
Prepaid expenses 2,481 3,009
Total current assets 25,096 20,669
Property and equipment, net 1,968 1,669
Right-of-use assets 1,137 1,210
Other assets 424 423
Total assets 28,625 23,971
Current liabilities:    
Trade payables 2,806 2,274
Accrued liabilities 8,403 7,355
Short-term lease liabilities 118 216
Other current liabilities 426 383
Total current liabilities 11,753 10,228
Long-term debt, net of unamortized discount and debt issuance costs 31,699 22,084
Revenue base redemption liability 564 507
Long-term lease liabilities 1,299 1,329
Contingent earnout liability 8,221 7,401
Warrant and SEPA liabilities 9,459 8,316
Total liabilities 62,995 49,865
Commitments and contingencies
Stockholders’ deficit:    
Preferred Stock, Convertible Series A, $0.0001 par value per share, $10.00 liquidation value per share. Authorized 10,000,000 shares at March 31, 2025 and December 31, 2024, respectively; issued and outstanding, 3,620,002 and 3,985,002 shares at March 31, 2025, and December 31, 2024, respectively. 0 0
Common stock, $0.0001 par value per share. Authorized 400,000,000 shares at March 31, 2025 and December 31, 2024, respectively; issued and outstanding, 32,272,462 and 31,279,264 shares at March 31, 2025, and December 31, 2024, respectively. 3 3
Additional paid-in capital 255,551 253,652
Accumulated deficit (289,924) (279,549)
Total stockholders’ deficit (34,370) (25,894)
Total liabilities and stockholders’ deficit $ 28,625 $ 23,971